Showing 1351-1360 of 1697 results for "".
- American Heart Association Releases Scientific Statement on Central Retinal Artery Occlusion, Calling it Eye Strokehttps://practicalneurology.com/news/american-heart-association-releases-scientific-statement-on-central-retinal-artery-occlusion-calling-it-eye-stroke/2469522/The American Heart Association and American Stroke Association have released a new scientific statement in Stroke, regarding central retinal artery occlusion (CRAO) as a form of ischemic stroke. The statemen
- Association Between Sleep Disturbances and Neuroimaging Biomarkers, Including White Matter Hyperintensities, Foundhttps://practicalneurology.com/news/association-between-sleep-disturbances-and-neuromaging-biomarkers-including-white-matter-hyperintensities-found/2470182/New research published in the May 10, 2023 issue of Neurology found an association between sleep disturbances, including obst
- Alzheimer’s Association Issues Its First Blood-Based Biomarker Guideline for Alzheimer’s Diagnosishttps://practicalneurology.com/news/alzheimers-association-issues-its-first-blood-based-biomarker-guideline-for-alzheimers-diagnosis/2475915/The Alzheimer’s Association has released its first clinical practice guideline with recommendations for the use of blood-based biomarker (BBM) tests in the diagnosis, treatment, and care of people with Alzheimer disease (AD). Presented at the 2025 meeting of the Alzheimer’s Association Internatio
- TIA Associated with Long-Term Cognitive Impactshttps://practicalneurology.com/news/tia-associated-with-long-term-cognitive-impacts/2473794/People who experience a first-time transient ischemic attack (TIA), even without visible brain injury on imaging, demonstrated accelerated long-term cognitive decline at a rate comparable to that observed after stroke. The results of a secondary data analysis of the ongoing Reasons for Geographic
- Retinal Changes Associated with Alzheimer Disease Confirmedhttps://practicalneurology.com/news/retinal-changes-associated-with-alzheimer-disease-confirmed/2470146/Accord
- Valbenazine Reduced Chorea Associated With Huntington Diseasehttps://practicalneurology.com/news/valbenazine-reduced-chorea-associated-with-huntington-disease/2469775/In a phase 3 study (NCT04102579), participants with Huntington disease (HD) treated with valbenazine (Ingrezza; Neurocrine Biosciences, San Diego, CA) had a reduction in chorea severity. Chorea re
- No Association Proven to Link Strep Throat and Neurologic Ticshttps://practicalneurology.com/news/no-association-proven-to-link-strep-throat-and-neurologic-tics/2469496/A study published in Neurology found no correlation between increased tic activity after getting strep throat. “The link between streptococcus and tics in children is st
- Insomnia May Be Associated With Increased Risk of Cognitive Impairmenthttps://practicalneurology.com/news/insomnia-may-be-associated-with-increased-risk-of-cognitive-impairment/2469389/A study published in Sleep showed that adults in midlife who had symptoms of insomnia and slept less than 6 hours a night were more likely to have cognitive impairment. The results may help healthcare providers understand which individuals are at increased risk of cognitive decline and dementia.&
- Vascular Diseases May Be Associated with Severe COVID-19https://practicalneurology.com/news/vascular-diseases-may-be-associated-with-severe-covid-19/2469353/Although COVID-19 was initially thought to be an infectious disease of the lungs, vascular inflammation and heart injury appear to be common features, occurring in 20% to 30% of hospitalized patients and contributing to 40% of deaths. The risk of death from COVID-19-related heart damage appears t
- Study Demonstrates Effectiveness of Finger Prick Method for Remote Collection and Quantification of Biomarkers Associated with Neurodegenerative Disordershttps://practicalneurology.com/news/study-demonstrates-effectiveness-of-finger-prick-method-for-remote-collection-and-quantification-of-biomarkers-associated-with-neurodegenerative-disorders/2470246/Results presented at the 2023 meeting of the Alzheimer’s Association International Conference (AAIC) in Amsterdam, The Netherlands, demonstrated the potential for remote collection and quan